MaxCyte Presents a Panel Discussion With Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery - LIVE Q&A to Follow

...ransfection System. Dr. Brady demonstrated how the maxcyte STX technology enables the large scale transfectio... relevant screening systems. According to maxcyte CEO Doug Doerfler, "We were delighted with the response to our previous webinar on the maxcyte STX technology and the interest in continuing with...

MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology

...ure present in any major hospital. About maxcyte maxcyte is the leader in providing clinical/commercial cel...cial and academic partners are currently using the maxcyte technology. The...

MaxCyte to Present at the BIO CEO & Investor Conference

...iotherapeutic manufacturing. About MaxCyte maxcyte is a clinical-stage cell therapeutics company with... of primary Pulmonary Arterial Hypertension (PAH). maxcyte has recently partnered with Medinet (JP) to commer...cial and academic partners are currently using the maxcyte technology. The...

MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008

... cardiopulmonary diseases. About MaxCyte maxcyte is a clinical-stage cell therapeutics company with... of primary Pulmonary Arterial Hypertension (PAH). maxcyte has recently partnered with Medinet (JP) to commer...cial and academic partners are currently using the maxcyte technology. The...

MaxCyte in Medical Technology

Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development

... based drug or GPCR screening). The cost-effective maxcyte ITF Inline Transfection system replaces current pr...efficiency and viability of cells processed by the maxcyte ITF Inline Transfection System make it possible to...lines and primary cells. About MaxCyte The maxcyte transfection platform was first designed, develope...

MaxCyte and Medinet to Present at the 13th Annual Meeting of the International Society for Cellular Therapy (ISCT) in Sydney, Australia

...ontracted Medical Institutions since 1999. About maxcyte maxcyte is a clinical-stage cell therapeutics company with...o commercializing successful cell-based therapies. maxcyte has demonstrated the value of its versatile techno...

MaxCyte in Biological Technology

The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays

GAITHERSBURG, Md., Oct. 22 /PRNewswire/ -- MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, announces that it will be launching the MaxCyte STX Scalable Transfection System at the Society for Biomolecular Sciences (SBS) Symposium "Cell Based Assays: Innovations in...

Binex and MaxCyte Collaborate on Cancer Immunotherapy Research

BUSAN, South Korea and GAITHERSBURG, Md., Nov. 30 /PRNewswire/ -- Binex (KOSDAQ: 053030) and MaxCyte, Inc. announced today the signing of a Sponsored Research Agreement to evaluate MaxCyte's GMP-compliant cell loading technology for use in closed-system manufacturing of Binex's cell-based canc...

Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan

GAITHERSBURG, Md. and YOKOHAMA, Japan, Aug. 27 /PRNewswire/ -- MaxCyte, Inc. and Medinet Co., Ltd. (TSE: #2370) announced today the signing of an exclusive license, development and supply agreement to use MaxCyte's proprietary cell loading system to support clinical studies and commercializati...

MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies

...THERSBURG, Md., Feb. 17 /PRNewswire-USNewswire/ -- maxcyte announces today the introduction of its GT(TM) Flo...l Stem Cell Summit to be held in New York, NY. The maxcyte GT(TM) Flow Transfection System is a validated, sc... billion cells, processed in under 30 minutes. The maxcyte GT(TM) Flow Transfection System enables consistent...

The MaxCyte(R) STX(TM) Scalable Transfection System to be Presented at the Rapid Fire Innovation Session at LabAutomation2009

...of Sales and Marketing, who will be presenting the maxcyte STX technology in the session. "The selection of the maxcyte STX for this session attests to the uniqueness of ...e's large scale transfection technology. Using the maxcyte STX, more than ten billion cells can be transfecte...

MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery

...(R) STX System. Dr. Brady will demonstrate how the maxcyte STX technology enables the large scale transfectio...in more relevant screening systems. According to maxcyte CEO Doug Doerfler, "We are delighted to have the e...uch a renowned industry expert as Dr. Reardon. The maxcyte STX is being viewed by the pharmaceutical industry...

MaxCyte and Medinet to Present at the 10th International Symposium on Dendritic Cells in Kobe, Japan

...f Medinet's cancer immunotherapy service in Japan. maxcyte has optimized its technology platform for Medinet'...ed in multiple clinical studies. About MaxCyte maxcyte is the leader in providing clinical/commercial cel...cial and academic partners are currently using the maxcyte technology. The MaxCyte system has an FDA Master F...

MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting

... will be conducting a Product Demonstration of the maxcyte STX Scalable Transfection System on Thursday, Sept...ident of Research and Development at MaxCyte, "The maxcyte STX Scalable Transfection System can be used to tr...ays MaxCyte President and CEO, Doug Doerfler. "The maxcyte STX can produce a large number of transfected cell...

MaxCyte to Present at BIO-Europe Spring 2008 Conference

...py as well as drug delivery. About MaxCyte maxcyte is a clinical-stage cell therapeutics company with... of primary Pulmonary Arterial Hypertension (PAH). maxcyte has recently partnered with Medinet (JP) to commer...cial and academic partners are currently using the maxcyte technology. The...